NYSE American: CANF

Can-Fite BioPharma Ltd. (CANF)

Can-Fite BioPharma Ltd. is a public company that reports to the U.S. Securities and Exchange Commission and trades on NYSE American under the ticker CANF. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
CANF
Exchange
NYSE American
SEC CIK
1536196
Official filings
SEC EDGAR

Research CANF

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Can-Fite BioPharma Ltd.'s stock ticker?

Can-Fite BioPharma Ltd. trades under the ticker symbol CANF on NYSE American. Its SEC Central Index Key (CIK) is 1536196.

Where can I read Can-Fite BioPharma Ltd.'s SEC filings?

The CANF SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Can-Fite BioPharma Ltd. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze CANF's financial statements?

The CANF Financials page shows Can-Fite BioPharma Ltd.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does CANF compare with its peers and the market?

The CANF Peer Comparison page lines Can-Fite BioPharma Ltd. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.